Cost-effectiveness study of three antimalarial drug combinations in Tanzania

PLoS Medicine

Volumn 3, Issue 10, 2006, Pages 1844-1850

  Wiseman, Virginia ^a   Kim, Michelle ^a   Mutabingwa, Theonest K ^a,b   Whitty, Christopher J M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; FANSIDAR; AMODIAQUINE, ARTESUNATE DRUG COMBINATION; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FANASIL, PYRIMETHAMINE DRUG COMBINATION; FLUORENE DERIVATIVE; PYRIMETHAMINE; SULFADOXINE;

ARTICLE; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; TANZANIA; WORLD HEALTH ORGANIZATION; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DRUG COMBINATION; DRUG COST; ECONOMICS; HEALTH CARE COST; INFANT; PRACTICE GUIDELINE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL (TOPIC); TIME; TREATMENT OUTCOME;

AMODIAQUINE; ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DRUG COMBINATIONS; DRUG COSTS; ETHANOLAMINES; FLUORENES; HEALTH CARE COSTS; HUMANS; INFANT; MALARIA; PRACTICE GUIDELINES AS TOPIC; PYRIMETHAMINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SULFADOXINE; TANZANIA; TIME FACTORS; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 33750854295     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030373     Document Type: Article

References (25)

1. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, et al. (1999) Averting a malaria disaster. Lancet 353: 1965-1967.
2. World Health Organization (2001) Antimalarial drug combination therapy: Report of a technical consultation. Geneva: WHO. 33 p.
3. Goodman C, Coleman PG, Mills AJ (1999) Cost-effectiveness of malaria control in sub-Saharan Africa. Lancet 354: 378-385.
4. Yeung S, Pongtavornpinyo W, Hastings IM, Mills AJ (2004) Antimalarial drug resistance, Artemisinin-based combination therapy, and the contribution of modelling to elucidating policy choices. Am J Trop Med Hyg 71: 179-186.
5. Whitty CJ, Allan R, Wiseman V, Ochola S, Nakyanzi-Mugisha MV, et al. (2004) Averting a malaria disaster in Africa - Where does the buck stop? Bull WHO 82: 381-384.
6. Wiseman V, Onwujekwe O, Matovu F, Mutabingwa T, Whitty C (2005) Differences in willingness to pay for amodiaquine+artesunate, amodiaquine+sulfadoxine-pyrimathamine, artemether-lumefantrine or monotherapy: Experiences from Tanzania. Bull WHO 83: 845-852.
7. Arrow KJ, Panosian CB, Gelband HEds (2004) Saving lives, buying time: Economics of malaria drugs in an age of resistance. Washington (DC): National Academy Press.
8. Morel C, Lauer J, Evans DB (2005) Achieving the millennium development goals for health: Cost effectiveness analysis of strategies to combat malaria in developing countries. BMJ 331: 1299.
9. Mutabingwa TK, Anthony D, Heller A, Hallett R, Ahmed J, et al. (2005) Amodiaquine alone, amodiaquine + sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: A four-arm randomized effectiveness trial. Lancet 365: 1474-1480.
10. Maxwell CA, Chambo W, Mwaimu M, Magogo F, Carneiro IA, et al. (2003) Variation in malaria transmission and morbidity with altitude in Tanzania and with introduction of alphacypermethrin treated nets. Malar J 10: 28.
11. Alilio MS, Kitua A, Njunwa K, Medina M, Ronn AM, et al. (2004) Malaria control at the district level in Africa: The case of Muheza district in northeast Tanzania. Am J Trop Med Hyg 71: 205-213.
12. Mutabingwa T, Nzila A, Mberu E, Nduati E, Winstanley P, et al. (2001) Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet 358: 1218-1223.
13. Green A (1999) An introduction to health planning in developing countries. 2nd Ed. Oxford: Oxford University Press.
14. Sanofi-Aventis and Drugs for Neglected Diseases initiative (DNDi) (2005) A collaborative agreement between DNDi foundation and Sanofi-Aventis to develop a new, easy to use malaria drug at target price below one dollar. Available at: http://en.sanofi-aventis.com/images/44_25583.pdf. Accessed: 01 September 2006.
15. World Health Organization (2006) Procurement of artemether-lumefantrine through the WHO. Available at: http://www.who.int/malaria/cmc_upload/0/000/015/ 789/CoA_website5.pdf Accessed: 01 September 2006.
16. Kindermans JM, Pecoul B, Perez-Casas C, Den Boer M, et al. (2002) Changing national malaria treatment protocols in Africa: What is the cost and who will pay? Case studies: Burundi, Kenya, Rwanda, Tanzania and Uganda. Medecins Sans Frontiers. 2002 Feb. Available at: http://www.accessmed-msf.org/ prod/publications.asp?scntid=25220021844238&contenttype=PARA&. Accessed: 01 September 2006.
17. Johns B, Baltussen R, Hutubessy R (2003) Programme costs in the economic evaluation of health interventions. Cost Eff Resour Alloc 1: 1.
18. Borghi J, Thapa B, Osrin D, Jan S, Morrison J, et al. (2005) Economic assessment of a women's group intervention to improve birth outcomes in rural Nepal. Lancet 366: 1882-1884.
19. Staedeke SG, Mpimbaza A, Kamya MR, Nzarubara BK, Dorsey G, at al. (2004) Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: Randomised clinical trial. Lancet 364: 1950-1957.
20. Barat L, Chipipa J, Kolczak M, Sukwa T (1999) Does the availability of blood slide microscopy for malaria at health centers improve the management of persons with fever in Zambia? Am J Trop Med Hyg 60: 1024-1030.
21. Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, et al. (2004) Over diagnosis of malaria in patients with severe febrile illness in Tanzania: A prospective study. BMJ 329: 1212-1218.
22. Garber AM, Phelps CE (1997) Economic foundations of cost-effectiveness analysis. J Health Econ 16: 1-31.
23. Kimemia P (2000) An overview of the performance of the East African economies since 1985: Implications for the new initiative on East African co-operation. Afr Sociol Rev 4: 119-137.
24. Equinet (2004) Equinet Newsletter 39: 01 May 2004. Available at: http://www.equinetafrica.org/. Accessed 01 September 2006.
25. Budlender (2002) Why should we care about unpaid care work? A guidebook prepared for the United Nations Development Fund for Women, Southern African Region Office, Harare, Zimbabwe. Available at: http://www.idrc.ca/uploads/user- S/11281120221Debbie_Budlender_Unpaid_CARE_work.pdf. Accessed 01 September 2006.